Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
Alzheimer’s Pipeline Drugs Review, Alzheimer’s Disease Drug Market & Forecast – Global Analysis

Alzheimer's drug market forecast to meet only 10% of unmet alzheimer's demand by 2018


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2014-03-17 14:35:02 - Alzheimer’s Pipeline Drugs Review, Alzheimer’s Disease Drug Market & Forecast – Global Analysis - a new market research report on companiesandmarkets.com

The alzheimer´s drug market has reported a significant number of drugs which have failed at the Phase III drug development pipeline phase. The global alzheimers drug market is expected to decline during the period 2009 to 2013 despite significant investment and interest in this area within the drug development sector and drug pipeline work. This new report is expecting the alzheimer´s drug market to recover and develop from 2017 as new drugs are launched and applied for human use. By 2018, the alzheimer´s drug development market is forecast to account for 10% of unmet demand.

A new study by Nottingham and Leicester Universities published in the Science Translational Medicine journal highlighted a new drug being developed which gave mice an oral

 

 

drug to prevent the brain from "switching off" its protein production. This new drug represents a key development in the fight against Alzheimer´s having been based on a drug compound originally developed by GlaxoSmithKline for a different purpose.

This drug being orally administered to mice has shown positive signs at halting the development of Prion, a similar brain disease to alzheimer´s, although there are significant side effects such as weight loss and the onset of mild diabetes and damage to the pancreas. However, the academic field are positive that this new study shows significant developments in getting drugs through the Phase III of the drug pipeline development and finally being applied for human use.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com